Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Veterinary Oncology Market Size Shifted, And What Is the Outlook Through 2034?

In the last few years, the veterinary oncology market has experienced swift expansion. The market, which stood at $0.4 billion in 2024, is projected to enlarge to $0.45 billion in 2025, with a compound annual growth rate (CAGR) of 12.3%. The historic period’s escalation can be linked to factors such as a jump in pet ownership, the treatment of pets as family members, application of knowledge from human oncology, heightened consciousness about pet health, and advancements in veterinary drugs.

How Much Will the Veterinary Oncology Market Be Worth in 2029?

The market for veterinary oncology is anticipated to experience swift expansion in the coming years, reaching a value of $0.69 billion in 2029, driven by a compound annual growth rate (CAGR) of 11.0%. This projected increase during the forecasting period could be due to factors such as the adoption of personalized treatments for animals, increasing instances of cancer in animals, a growing elderly pet demographic, more available specialized care, and regulatory support and approval. Significant trends during this forecast period include the progression of diagnostic technologies, personalized treatment methods, advancements in immunotherapy, targeted treatments, and the use of telemedicine for oncology consultations.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9533&type=smp

Which is the Largest Company in the Veterinary Oncology Market?

Major companies operating in the veterinary oncology market include PetCure Oncology Inc., Zoetis Inc., Karyopharm Therapeutics Inc., Varian Medical Systems Inc., Accuray Incorporated, Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., One Health Company Inc., Regeneus Limited, VetDC Inc., Pharmaust Limited, AdvaVet Inc., Nippon Zenyaku Kogyo Company Limited, Rhizen Pharmaceutical SA, AB Science SAS, Pfizer Inc., Takis Biotech GmbH, Qbiotics LLC, Jaguar Animal Health Solutions Inc., Orion Corporation A/B, Invectys S.A., Virbac SA, SeQuent Scientific Limited, Ceva Santé Animale S.A., Vetoquinol S.A., IDVet Inc., Bayer Aktiengesellschaft, Morphogenesis Inc., ZENOAQ GmbH, Oncovet Clinical Research Inc.

What Are the Main Market Drivers in the Veterinary Oncology Industry?

The rising incidence of cancer among household animals is anticipated to boost the growth of the veterinary oncology market. The anomaly of cancer arises when certain body cells multiply uncontrollably and invade other parts of the body. When it comes to pets, cancer refers to the visible signs such as tumors and swellings. Veterinary oncology primarily deals with the detection and treatment of cancer in animals, aiming to limit disease diffusion and metastasis. Consequently, an upswing in the rates of pet cancer will amplify the demand for veterinary oncology. For example, The Cancer Letter, a U.S. news publication focusing on cancer research, projected that about 6 million pet dogs in the U.S will be diagnosed with cancer in 2024. Moreover, the British Small Animal Veterinary Association (BSAVA), a UK-based animal health organization, estimated in November 2023, that 1 in 4 dogs and 1 in 5 cats would get a cancer diagnosis in their lifespan. Therefore, the escalating occurrence of cancer in pets is fueling the expansion of the veterinary oncology market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9533&type=smp

How Is the Veterinary Oncology Market Segments Structured?

The veterinary oncology market covered in this report is segmented –

1) By Therapy: Surgery, Radiology, Chemotherapy, Other Therapies

2) By Animal Type: Equine, Canine, Feline, Other Animal Types

3) By Cancer Type: Lymphoma, Mast Cell Cancer, Mammary And Squamous Cell Cancer, Other Cancer Types

Subsegments:

1) By Surgery: Tumor Resection, Palliative Surgery, Laparoscopic Surgery, Amputation

2) By Radiology: Radiation Therapy, Stereotactic Radiosurgery, Brachytherapy, Imaging Techniques

3) By Chemotherapy: Injectable Chemotherapy, Oral Chemotherapy, Combination Chemotherapy Protocols, Targeted Therapy Agents

4) By Other Therapies: Immunotherapy, Photodynamic Therapy, Supportive Care, Alternative Therapies

What Strategic Trends Are Transforming the Veterinary Oncology Market?

Leading businesses in the veterinary oncology market are concentrating on the progress of neoantigens, which are distinct antigens occurring from mutations in cancer cells and are unique to the tumor. Unlike antigens found in non-diseased tissues, these neoantigens result from genetic alterations within the DNA of the tumor. For instance, in October 2024, Biotechnology company, a firm based in the US initiated a cancer vaccine trial for dogs. The utilization of neoantigens in the crafting of cancer vaccines and other types of immunotherapy is under exploration, with the intent of amplifying the immune response to combat cancer cells specifically, while leaving normal cells untouched.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/veterinary-oncology-global-market-report

Which Global Regions Offer the Highest Growth in the Veterinary Oncology Market?

The countries covered in the veterinary oncology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9533

This Report Delivers Insight On:

1. How big is the veterinary oncology market, and how is it changing globally?

2. Who are the major companies in the veterinary oncology market, and how are they performing?

3. What are the key opportunities and risks in the veterinary oncology market right now?

4. Which products or customer segments are growing the most in the veterinary oncology market?

5. What factors are helping or slowing down the growth of the veterinary oncology market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model